FY2028 EPS Estimate for COMPASS Pathways Lowered by Analyst

COMPASS Pathways plc (NASDAQ:CMPS) – Stock analysts at HC Wainwright dropped their FY2028 earnings per share estimates for shares of COMPASS Pathways in a research report issued on Thursday, February 13th. HC Wainwright analyst P. Trucchio now forecasts that the company will post earnings per share of $0.14 for the year, down from their prior forecast of $0.24. HC Wainwright currently has a “Buy” rating and a $45.00 price objective on the stock. The consensus estimate for COMPASS Pathways’ current full-year earnings is ($2.33) per share. HC Wainwright also issued estimates for COMPASS Pathways’ FY2029 earnings at $1.63 EPS.

A number of other brokerages also recently issued reports on CMPS. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $18.00 target price on shares of COMPASS Pathways in a research note on Wednesday, January 15th. Maxim Group cut their price objective on COMPASS Pathways from $22.00 to $12.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Six analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $30.60.

COMPASS Pathways Stock Up 3.4 %

Shares of CMPS opened at $4.57 on Friday. COMPASS Pathways has a 52-week low of $3.16 and a 52-week high of $12.75. The company has a market capitalization of $312.68 million, a PE ratio of -2.08 and a beta of 2.28. The stock has a fifty day simple moving average of $4.10 and a two-hundred day simple moving average of $5.49. The company has a quick ratio of 8.91, a current ratio of 8.91 and a debt-to-equity ratio of 0.15.

Institutional Trading of COMPASS Pathways

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Jane Street Group LLC increased its position in shares of COMPASS Pathways by 72.7% during the 4th quarter. Jane Street Group LLC now owns 51,815 shares of the company’s stock worth $196,000 after purchasing an additional 21,815 shares during the last quarter. AdvisorShares Investments LLC grew its position in COMPASS Pathways by 51.8% in the 4th quarter. AdvisorShares Investments LLC now owns 66,602 shares of the company’s stock valued at $252,000 after acquiring an additional 22,720 shares in the last quarter. Nantahala Capital Management LLC grew its position in COMPASS Pathways by 400.0% in the 4th quarter. Nantahala Capital Management LLC now owns 1,000,000 shares of the company’s stock valued at $3,780,000 after acquiring an additional 800,000 shares in the last quarter. Virtus ETF Advisers LLC grew its position in COMPASS Pathways by 21.4% in the 4th quarter. Virtus ETF Advisers LLC now owns 16,121 shares of the company’s stock valued at $61,000 after acquiring an additional 2,840 shares in the last quarter. Finally, Two Sigma Securities LLC acquired a new position in COMPASS Pathways in the 4th quarter valued at about $135,000. 46.19% of the stock is owned by institutional investors and hedge funds.

About COMPASS Pathways

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.